NEW YORK (GenomeWeb News) – Exact Sciences today reported flat revenues year over year for its fourth quarter, matching the consensus analyst estimate on the top line and beating it on the bottom line.

The Madison, Wis.-based molecular diagnostics company took in $1.0 million in revenues for the three months ended Dec. 31, 2013, the same as a year ago. Revenues for Q4 2013 and the year-ago period derived from licensing fees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.